Evolus, Inc. IPO Research Information

Evolus, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Evolus, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Evolus, Inc.	EOLS - NASDAQ	$12.00-$14.00	$12.00	$11.25	5 million	2/8/2018
Underwriter(s): Cantor, Mizuho Securities
Co-Manager(s): SunTrust Robinson Humphrey, JMP Securities
Industry: Health Care
Filing(s): Filed 2018-01-09 Terms Added 2018-01-29 Final Prospectus 2018-02-09

Evolus, Inc. Quote & Chart - Click for current quote - EOLS

About Evolus, Inc. (adapted from Evolus, Inc. prospectus):
They are a medical aesthetics company focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "EOLS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.